disulfide, has been isolated, and its novel disulfide bond linkage system was identified by a chemical synthetic method. The supposed conformation constrained in 3D structure for isomer V would be discussed for its biological activity.
Insulin-like growth factor I (IGF-I or somatomedin C) is a serum factor with growth promoting and metabolic activities, 4) which circulates through the body bound by several IGF binding proteins (IGFBPs). It is considered to mediate the action of longitudinal growth promotion by growth hormone secreted from the pituitary. It also has intrinsic activity of glucose uptake promotion through its IGF receptor. Based on these biological activities, IGF-I has been approved in Japan to treat growth hormone resistant dwarfism and diabetes mellitus caused by a genetic insulin receptor defect. IGF-I consists of 70 amino acid residues with three internal disulfide bonds formed by six internal cysteines; the primary structure was determined by Rinderknecht and Humbel in 1978 (Fig. 1) . 5) During the course of IGF-I preparation by the recombinant DNA method, 6, 7) we found the presence of several IGF-I disulfide bond isomers (Fig. 2) . In previous reports, [8] [9] [10] [11] [12] we reported the isolation of three disulfide bond isomers, isomer I, II, and IV, and the determination of disulfide bond linkages. In all respects of the analyses, isomer II was identified as natural IGF-I. Isomer I has a disulfide bond linkage of Cys 6 48 . In spite of the speculated conformational similarity between isomer II and I from the disulfide linkages, a bioassay of growth promoting activity by 3 H-thymidine uptake revealed the activity order as isomer IIϾIVϾI. 8, 13) Here, we report the isolation of a new disulfide bond isomer which doesn't have Cys 18 -Cys 61 disulfide, common to the previously identified IGF-Is. Also, we report in detail 14, 15) the determination of its disulfide linkage system by a synthetic chemical method in a manner similar to that the applied for isomer I and II. [10] [11] [12] This approach of determining the position in the coordinate of key residues should provide hints for synthesizing protein mimics in the future.
Cell growth promoting activity and binding activity to IGFBP-2 and -3 are also reported with the discussion of the conformation in 3D structures for the isomers.
A reduced form of recombinant h-IGF-I in 6 M guanidine HCl-10 mM Tris-HCl (pH 8.0) with 10-fold 10 mM Tris-HCl buffer (pH 8.0) was subjected to air-oxidation to cause refolding. Four main peaks, designated isomer I, II, IV, and V(1) (Fig. 2) , were isolated by preparative RP-HPLC.
An outline for the structural determination of a new disulfide isomer of h-IGF-I, isomer V(1), is shown in Fig. 3 The protected peptide resins, fully protected 18-Acm h-IGF-I (17-21)-resin, 47-Acm h-IGF-I (37-55)-resin, and 48-Acm h-IGF-I (37-55)-resin, were assembled manually by Boc/Bzl-based solid phase peptide synthesis using Merrifield resin, on Boc-Arg(Tos)-OCH 2 C 6 H 4 -resin, as shown in Fig. 5 .
All amino acids were protected at their amino groups with a Boc group, and the side chain protecting groups were OBzl for Ser and Thr, Tos for Arg, OcHx for Asp and Glu, Acm or MBzl for Cys. Coupling reactions were carried out with a 2-fold excess of pre-prepared Boc amino acid anhydride, 16) and in the case of the coupling reactions for Boc-Gln and Boc-Arg(Tos), with a 2-fold excess of their HOBt esters which were pre-prepared from Boc amino acid, HOBt, and DCC. After the cleavage from the resin and deprotection, except for the Cys(Acm) group with anhydrous liquid HF containing 10% anisole, 6 was obtained, while the intrachain disulfide bonds of 7 and 7 were formed from the fully protected peptide resin by oxidation in 0.1 M K 3 [Fe(CN) 6 ] following cleavage from the resin and deprotection procedure as for 6 (Fig. 5 ). The purity of synthetic peptides was confirmed by analytical HPLC on a C 18 column and by amino acid analysis with a Waters Pico-Tag system.
Coupling, interchain disulfide bond formation, of 6 with 7 or 7 under Kamber's condition by I 2 /HCl in MeOH 17) produced the heterodimer 8 or 8, along with the respective homodimers (Figs. 6, 7).
After the purification of produced heterodimers by RP-HPLC, 8 and 8 were digested by chymotrypsin in 0.1 M (NH 4 )HCO 3 at RT for 60 min to obtain the form I (5) and II (5). 8 afforded 5, but chymotrypsin digestion of 8 to obtain the form I (5) failed because of steric hindrance of the cyclic domain containing a disulfide linkage with -Phe 49 -Arg 50 -for the enzyme in 8. So, in the case of the preparation of 5, before the heterodimeric reaction between 6 and 7, we tried to digest the bond of -Phe 49 -Arg 50 -in 7 by chymotrypsin to form 9 in good yield. Interchain disulfide bond formation, of 6 with 9 in a similar manner as in the synthesis of 8 or 8 by I 2 /HCl in MeOH, produced the heterodimer 5 along with the respective homodimers (Fig. 8 ). 5 and 5 were identified by comparing the retention time on RP-HPLC ( Fig. 9) , amino acid analyses, measurements of FAB-MS (Found m/zϭ2732Ϯ1, Calcd 2731.9), and mapping of 2-ME reduced peptides, and its amino acid analysis as 5 obtained from h-IGF-I isomer V(1). Thus, the new disulfide linkage system of 1 was absolutely determined to be Cys 6 -Cys 61 , Cys 18 -Cys 48 , and Cys 47 -Cys 52 . Although 1 (isomer V) and isomer I have similar affinity, 0.1-0.2% of IGF-I, to IGFBP-2 and -3, 1 showed distinctive activity in the cell growth promoting assay from isomer I; 1 retains only 11.1% activity of isomer I (Table 1) . 3D structures of isomer I and isomer II have been determined by NMR NOE data and distance geometry algorithm calculation in hopes of explaining the conformation activity relationship. [18] [19] [20] Isomer II (IGF-I) was revealed to have three a-helix domains (helix I: Ala 8 -Cys 52 (isomer IV) in three former isomers, is quite different from the isomers. The conformational changes in simulated 3D structures were coincident with the order of biological activities of these four isomers. Studies along these lines are now in progress in our laboratory.
Experimental
Amino acid analysis of each peptide was carried out with Water's PicoTag amino acid analysis System (OPA method) after hydrolysis for 24 h in HCl (5.7 mol/l) at 110°C in an evacuated tube. Amino acid sequences of peptides were determined by Applied Biosystem's Model 476A Sequencer. HPLC were performed by use of a Waters M600 multisolvent delivery system, a Shimadzu LC-6A, and a LC-10AS liquid chromatograph system. FAB-MS spectra were obtained on a Finnigan MAT TSQ-70 spectrometer. TOF-MS spectra were obtained on a Voyager Elite spectrometer (PE Biosystems, Foster City, CA). h-IGF-I was produced by a recombinant DNA technique in our laboratory.
6,7) a-Chymotrypsin and trypsin were from Sigma Chemical (St. Louis, MO, U.S.A.). For the peptide synthesis, Boc amino acid derivatives, Boc-Arg(Tos)-resin, DCM, DMF, TFA, and DIEA were from Watanabe Chemical Industries (Hiroshima, Japan), and DCC and HOBt were from Peptide Institute, Inc. (Osaka, Japan). Isolation of Isomer V(1) Recombinant IGF-I was produced by Escherichia coli and purified as reported. 7) IGF-I (135 mg), a reduced form, 7) was dissolved in 6 M guanidine HCl-10 mM Tris-HCl buffer (pH 8.4) (40 ml), and then diluted with a 10-fold volume of 10 mM Tris-HCl buffer (pH 8.4) to cause refolding and air-oxidation. The mixture was analyzed by RP-HPLC (Fig. 2) , and then IGF-I and its disulfide bond isomers containing isomer V(1) were isolated from the refolding mixture by preparative RP-HPLC with a linear gradient of CH 3 CN from 27 to 38% in 30 min in 0.01 M TFA in a similar manner to the case of the reported IGF-I. (1 minϫ8). The solution of a 2-fold excess of Boc amino acid anhydride, 18) pre-prepared with Boc amino acid and DCC in DCM-DMF, was added to the resin and the mixture was shaken for 15 min as the coupling step. The solution of 20% DIEA in DCM was added, and the mixture was shaken for 15 min. After washing of the resin with DCM (1 minϫ3), the coupling efficiency was checked by Kaiser's Ninhydrin test, 21) which indicated the disappearance of the free amino group. In the case of an incomplete condensation reaction at the N-terminus, observed in the free amino group by the above test, the resin was recoupled by the same manner until the test indicated the disappearance of the free amino group. The resin was washed with DCM (1 minϫ3), then subjected to the next condensation cycle. After introducing the last Boc amino acid, Boc-Val, the resin was washed with EtOH (1 minϫ2) and filtered, washed by DCM, DCM-EtOH (1/1, v/v), and EtOH, then dried in vacuo to yield Boc, fully protected 18-Acm h-IGF-I (17-21)-resin (Yield 5.832 g, weight of increase 0.943 g, 73.88%).
Boc, Fully Protected 47-Acm h-IGF-I (37-55)-Resin
Starting from Boc-Arg(Tos)-resin (0.5 meq/g, 1.500 g), Boc, fully protected 47-Acm h-IGF-I (37-55)-resin was prepared in a similar manner as described above and as shown in Fig. 5 . In the case of the introduction of Boc-Gln and Boc-Arg(Tos), a 2-fold excess of their HOBt esters pre-prepared with Boc amino acid, HOBt, and DCC were used instead of their anhydrides. (Yield 3.585 g, weight of increase 2.085 g, 89.4%).
Boc, Fully Protected 48-Acm h-IGF-I (37-55)-Resin
Starting from Boc-Arg(Tos)-resin (0.5 meq/g, 1.500 g), Boc, fully protected 48-Acm h-IGF-I (37-55)-resin was prepared in a similar manner as described above and as shown in Fig. 5. (Yield 3.406 g, weight of increase 1.906 g, 79.33% ).
18-Acm h-IGF-I (17-21) (6) Boc, fully protected 18-Acm h-IGF-I (17-21)-resin (2.7085 g) was treated with anhydrous HF (30 ml) and anisole (2.5 ml) at 0°C for 60 min (Fig. 5) . After evaporation of the HF, ether (30 ml) was added to the mixture, and the precipitate obtained was washed with ether (30 mlϫ3), then extracted with water (10 mlϫ5). The aqueous solution was washed with ether (50 mlϫ2) and the aqueous layer was applied to a column of Dowex 1ϫ2 (AcO 47-Acm h-IGF-I (37-55) (7) Boc, fully protected 47-Acm h-IGF-I (37-55)-resin (1.728 g) was treated with anhydrous HF (30 ml) and anisole (2.5 ml) at 0°C for 60 min (Fig. 5) . After evaporation of the HF, ether (30 ml) was added to the mixture, and the precipitate obtained was washed with ether (30 mlϫ3), then extracted with water (10mlϫ5). The aqueous solution was washed with ether (50 mlϫ2) and the aqueous layer was applied to a column of Dowex 1ϫ2 (AcO Ϫ , 2ϫ10 cm). The passed solution (100 ml) and washings (1 M AcOH, 200 ml) were combined, and were then adjusted to pH 7.5 by 2 M NaOH, followed by intramolecular disulfide bond formation by 0.1 M K 3 [Fe(CN) 6 ] (10 ml) for 10 min at RT. The reaction mixture was acidified at pH 5.0 by AcOH, treated with an Amberlite IRA 94s (Cl Ϫ type) column (1.8ϫ13 cm) to remove the color and SEP-PAK (C 18 ) to remove the inorganic salt, and lyophilized to give crude 47-Acm h-IGF-I (37-55) ( Acm h-IGF-I (37-49, 50-55) (9) 47-Acm h-IGF-I (37-55) (7) (1.0 mg) in 10% (NH 4 )HCO 3 (10 ml) and water (90 ml) was digested with achymotrypsin (10 mg) in 0.001 M HCl (1.0 ml) (pH 8.0) at an E/S ratio of 1/100 (w/w) for the enzyme, at 23°C for 2 h. After the addition of acetic acid (pH 4.0) to stop the reaction, products were purified by RP-HPLC to obtain 47-Acm h-IGF-I (37-49, 50-55) (9) Biological Activities Cell growth promoting activity was measured using BALB/c 3T3 fibroblasts grown under a serum-free condition. The detection of bioactivity was performed colorimetrically. 22) Binding affinities to human IGFBP-2 and IGFBP-3 were evaluated by a competition assay with 125 I-IGF-I.
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